These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 983044)

  • 21. [Clinical evaluation of the oral hypoglycemic agent glipizide].
    Lin JD; Huang MJ; Huang BY; Huang HS
    Changgeng Yi Xue Za Zhi; 1986 Sep; 9(3):171-7. PubMed ID: 3454708
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of hemoglobin A1c for the evaluation of metabolic equilibrium in patients with non-insulin-dependent diabetes treated with glipizide].
    Remy C; Schoos R; Luyckx A; Lefèbvre P
    Rev Med Liege; 1980 May; 35(10):393-8. PubMed ID: 7466047
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
    Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
    Borisova AM; Taneva T; Koev D; Georgieva R
    Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glipizide: a new second generation sulfonylurea.
    Norris E
    Adv Exp Med Biol; 1979; 119():427-34. PubMed ID: 495296
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New perspectives in noninsulin-dependent diabetes mellitus and the role of glipizide in its treatment. Proceedings of a symposium.
    Am J Med; 1983 Nov; 75(5B):1-99. PubMed ID: 6673593
    [No Abstract]   [Full Text] [Related]  

  • 30. Glipizide pharmacokinetics and response in diabetics.
    Huupponen R; Seppälä P; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):417-22. PubMed ID: 6754633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic and hormonal response to a standardized breakfast in type 2 diabetes. Effect of glipizide].
    Scheen AJ; de la Torre D; Luyckx AS; Lefèbvre PJ
    Rev Med Liege; 1983 Mar; 38(6):189-98. PubMed ID: 6344171
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glipizide in the treatment of non-insulin-dependent diabetes mellitus].
    Luis Iriarte J
    Rev Clin Esp; 1989 Jun; 185(1):24-32. PubMed ID: 2772334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The second generation sulfonylureas: glipizide and glyburide.
    Baker DE; Campbell RK
    Diabetes Educ; 1985; 11(3):29-36. PubMed ID: 3935402
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics.
    Wåhlin-Boll E; Almér LO; Melander A
    Clin Pharmacokinet; 1982; 7(4):363-72. PubMed ID: 7116738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
    Lebovitz HE; Feinglos MN; Bucholtz HK; Lebovitz FL
    J Clin Endocrinol Metab; 1977 Sep; 45(3):601-4. PubMed ID: 903405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
    Villaseñor A
    Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
    [No Abstract]   [Full Text] [Related]  

  • 37. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glipizide on platelet function and fibrinolytic activity.
    Ketsa K; Jererat S; Nitiyanant W; Suwanwattana K
    J Med Assoc Thai; 1987 Oct; 70(10):578-82. PubMed ID: 3694080
    [No Abstract]   [Full Text] [Related]  

  • 39. Glipizide ('Glibenese') in maturity-onset diabetes mellitus.
    Klaassen CH
    Curr Med Res Opin; 1979; 6(1):8-13. PubMed ID: 378559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The second generation oral sulfonylureas: glyburide and glipizide.
    Kuhn T
    Am Pharm; 1988 Oct; NS28(10):55-61. PubMed ID: 3143256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.